Guyana vs Southern Asia: Proportion of the target population who received a 3rd dose of
Guyana
98.0%
in 2024
Southern Asia
88.0%
in 2024
Guyana rank
7th
Southern Asia rank
4th
Proportion of the target population who received a 3rd dose of over time
- Guyana
- Southern Asia
How they compare
Guyana currently reports 98.0% against 88.0% in Southern Asia, a difference of 10.0%.
That makes Guyana's figure about 1.1 times Southern Asia's.
Across all 12 years both countries report, Guyana has been ahead every year.
Guyana ranks 7th and Southern Asia ranks 4th of 157 countries.
Guyana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guyana | Southern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.0% | 22.9% | 72.1% | Guyana |
| 2020s | 95.8% | 64.2% | 31.6% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Guyana or Southern Asia?
- Guyana, at 98.0% against 88.0% in Southern Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Guyana and Southern Asia?
- 10.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Southern Asia?
- 12 years are reported by both, from 2013 to 2024.
- How do Guyana and Southern Asia rank globally for proportion of the target population who received a 3rd dose of?
- Guyana ranks 7th and Southern Asia ranks 4th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.